Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Synagis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Synagis was produced by AstraZeneca and AbbVie.

Ablynx spurns Novo Nordisk and cuts €3.9bn deal with Sanofi

Ablynx spurns Novo Nordisk and cuts €3.9bn deal with Sanofi AZ sells a prophylactic RSV antibody - Synagis (palivizumab) - which brought in $677m in sales in 2016 despite being reserved for use in high-risk infants.

Regeneron drops RSV drug

Regeneron drops RSV drug At the moment the only approved prophylaxis against the virus is AZ's Synagis (palivizumab) which brought in $677m in sales last year. ... Synagis has previously been a $1bn-plus product, but has seen its sales shrink thanks to the start of generic

Sanofi buys into AZ drug for preventing RSV infections

Sanofi buys into AZ drug for preventing RSV infections The deal also includes up to 495m in development and sales milestone payments and focuses on MEDI8897, a follow-up to AZ's already-marketed Synagis (palivizumab) which is the first ... Synagis brought in $677m in sales for AZ last year, with sales down

AZ slims down again with sale of antibiotics to Pfizer

AZ slims down again with sale of antibiotics to Pfizer The agreement does not include biologic anti-infective products coming from AZ's Medimmune unit - notably Synagis (palivizumab) for respiratory syncytial virus (RSV) infections and flu vaccine FluMist - or indeed a

AbbVie is not looking at another big acquisition, says CEO

AbbVie is not looking at another big acquisition, says CEO Among these Synthroid (levothyroxine) for hypothyroidism grew 24% to $200m, despite its maturity and plenty of generic competition, while respiratory syncytial virus (RSV) drug Synagis (palivizumab) rose 18% to $109m.

[ Previous 5 results ] 1 2 3 4 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Health

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....